No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Physicians Committee for Responsible Medicine · Other
Who this trial is looking for
This trial is looking for adults with type 2 diabetes who want to lose weight through a plant-based diet. Participants will attend weekly meetings with a doctor and dietitian for 12 weeks to learn about nutrition and make dietary changes.
Are You a Good Fit for This Trial?
Must not be takingGLP-1 receptor agonists
You may be able to join if
I am at least 19 years old.
I have a body mass index (BMI) of 25 or more.
I can travel to Washington DC for scans.
I can complete tests at a local LabCorp facility.
I have access to the internet.
I can speak and understand English.
You may not be able to join if
I have used recreational drugs in the past 6 months.
I am pregnant or plan to become pregnant during the study.
I have an unstable medical or psychiatric condition.
I cannot follow my medication regimen as prescribed.
I am using any weight loss medication now or have used one in the past year.
My weight is greater than 182 kg.
I have a current diagnosis of an eating disorder.
I intend to use another weight loss method during the study.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will meet with a physician and a registered dietitian once a week to learn about a plant-based diet and receive support and practical help in making the dietary changes. Body composition, blood sugar co…
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Participants will meet with a physician and a registered dietitian once a week to learn about a plant-based diet and receive support and practical help in making the dietary changes. Body composition, blood sugar control, cholesterol levels, and food costs will be measured at the start and end of the study.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* U.S. men and women meeting the age of majority, defined as follows:
Age 19 or older in Nebraska and Alabama. Age 21 or older in Puerto Rico. Age 18 or older in all other states.
* Able and willing to travel to Washington DC for a dual-energy х-rау absorptiometry (DXA) scans …
Inclusion Criteria:
* U.S. men and women meeting the age of majority, defined as follows:
Age 19 or older in Nebraska and Alabama. Age 21 or older in Puerto Rico. Age 18 or older in all other states.
* Able and willing to travel to Washington DC for a dual-energy х-rау absorptiometry (DXA) scans before and after the program.
* Able and willing to complete laboratory assessments at a local LabCorp facility before and after the program.
* Able and willing to participate in all components of the study.
* BMI of 25 or more (23 or more in persons of Asian origin).
* Access to the internet.
* English fluency.
Exclusion Criteria:
* Use of recreational drugs in the past 6 months.
* Pregnancy or intention to become pregnant during the study period, as verified by self-report.
* Unstable medical or psychiatric illness.
* Inability to maintain medication regimen as prescribed by personal healthcare provider.
* Current or expected use of any weight loss medication during the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists.
* Use of any weight loss medication within the 12 months preceding the study period, including but not limited to, glucagon-like peptide-1 (GLP-1) receptor agonists and combination GLP-1 receptor/glucose-dependent insulinotropic polypeptide (GIP) agonists.
* Body weight greater than 182 kg.
* Current diagnosis of eating disorder.
* Intention to follow another weight loss method during the study period.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.